mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.045 |
0.4 |